University of Colorado
Pathology residency · Aurora, CO · Program website
This program's roster hasn't been collected yet, so there's no list of its own faculty and papers. Below is University of Colorado Anschutz's research in pathology, which the program shares with other departments and affiliated hospitals.
About University of Colorado Anschutzinstitution-wide pathology research
Pathology publications from University of Colorado Anschutz and affiliated institutions, since 2022. Updated 2026-11-06; refreshed daily.
84
works per year
10th of 65 pathology residency programs
+26.4%
2-year growth
13th of 65 pathology residency programs
19.6%
in top 10% of field (works before 2025)
27th of 56 pathology residency programs
42.5%
cited above world average
27th of 56 pathology residency programs
Works per year · * 2026 so far
Pathology and Forensic Medicine · 425
Pathology research topics at University of Colorado Anschutz
Papers in the window; each links to the list on OpenAlex.
Most cited at University of Colorado Anschutz since 2024
All pathology papers there on OpenAlex
- Cytosolic phospholipase A2 in infiltrating monocyte derived macrophages does not impair recovery after spinal cord injury in female miceEthan P. Glaser et al. · Scientific Reports · 2025 · PubMed · cited 318
- Emerging Cerebrospinal Fluid Biomarkers of Disease Activity and Progression in Multiple SclerosisAnne Haney Cross et al. · JAMA Neurology · 2024 · PubMed · cited 107
- Safety and efficacy of inebilizumab for the treatment of neuromyelitis optica spectrum disorder: end-of-study results from the open-label period of the N-MOmentum trialBruce Cree et al. · The Lancet Neurology · 2024 · PubMed · cited 71
- Senescent-like microglia limit remyelination through the senescence associated secretory phenotypePhillip S. Gross et al. · Nature Communications · 2025 · PubMed · cited 65
- Randomized trial of standard chemotherapy alone or combined with atezolizumab as adjuvant therapy for patients with stage III deficient DNA mismatch repair (dMMR) colon cancer (Alliance A021502; ATOMIC).Frank A. Sinicrope et al. · Journal of Clinical Oncology · 2025 · cited 59
- Real-world outcomes of patients with aggressive B-cell lymphoma treated with epcoritamab or glofitamabTaylor Brooks et al. · Blood · 2025 · PubMed · cited 45
- Prognostic value of tissue bridges in cervical spinal cord injury: a longitudinal, multicentre, retrospective cohort studyDario Pfyffer et al. · The Lancet Neurology · 2024 · PubMed · cited 44
- Long-Term Efficacy of Teprotumumab in Thyroid Eye Disease: Follow-Up Outcomes in Three Clinical TrialsGeorge Jean Kahaly et al. · Thyroid · 2024 · PubMed · cited 42
- Advancing multiple sclerosis management in older adultsAnneke van der Walt et al. · Nature Reviews Neurology · 2025 · PubMed · cited 40
- Derivation and external validation of a simple risk score for predicting severe acute kidney injury after intravenous cisplatin: cohort studyShruti Gupta et al. · BMJ · 2024 · PubMed · cited 40